ICLR+5.21%20.0%
IQV+32.99%20.0%
MEDP+36.57%16.0%
CRL+73.43%14.0%
FTRE+189.51%11.0%
TMO+28.71%10.0%
LH+20.36%9.0%
As of Aug 6, 2026, 4:25 AM ET
MedTech Long '26: CROs Constituents
ICON Public Limited CompanyICLR | 20.0% | 4.25% | -1.36% | -4.35% | -0.04% | -10.27% | 51.20% | -3.08% | 5.21% | $12.52B |
IQVIA Holdings Inc.IQV | 20.0% | 3.44% | 13.46% | 14.60% | 0.44% | 4.72% | 32.01% | 35.37% | 32.99% | $39.40B |
Medpace Holdings, Inc.MEDP | 16.0% | 2.20% | -2.27% | 4.01% | 1.84% | 4.65% | 30.10% | 88.85% | 36.57% | $16.41B |
Charles River Laboratories International, Inc.CRL | 14.0% | 11.36% | 15.07% | 12.66% | 12.13% | 30.70% | 46.07% | 74.65% | 73.43% | $12.56B |
Fortrea Holdings Inc.FTRE | 11.0% | 5.89% | -2.41% | 6.72% | -0.63% | 10.43% | 77.71% | 153.66% | 189.51% | $1.80B |
Thermo Fisher Scientific Inc.TMO | 10.0% | 2.32% | 1.68% | 11.64% | 0.61% | -0.28% | 10.88% | 18.15% | 28.71% | $214.73B |
Labcorp Holdings Inc.LH | 9.0% | 0.52% | 5.79% | 10.40% | 1.54% | 25.14% | 8.59% | 32.83% | 20.36% | $25.74B |
| Theme return | — | 4.41% | 4.59% | 7.25% | 1.84% | 11.32% | 39.22% | 59.67% | 45.53% | — |
| Average | 14.3% | 4.28% | 4.28% | 7.95% | 2.27% | 9.30% | 36.65% | 57.20% | 55.25% | $46.17B |
| Median | 14.0% | 3.44% | 1.68% | 10.40% | 0.61% | 4.72% | 32.01% | 35.37% | 32.99% | $16.41B |
| Std Dev | 4.2% | 3.29% | 6.86% | 6.03% | 4.10% | 13.24% | 22.37% | 49.05% | 58.10% | $69.69B |
| Min | 9.0% | 0.52% | -2.41% | -4.35% | -0.63% | -10.27% | 8.59% | -3.08% | 5.21% | $1.80B |
| Max | 20.0% | 11.36% | 15.07% | 14.60% | 12.13% | 30.70% | 77.71% | 153.66% | 189.51% | $214.73B |
| % Positive Tickers | 100.00% | 57.14% | 85.71% | 71.43% | 71.43% | 100.00% | 85.71% | 100.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondary
About this theme
MedTech Long '26: CROs tracks 7 publicly listed stocks in this theme: CRL, FTRE, ICLR, IQV, LH, MEDP, TMO. See the constituent table for details.